David Bernstein

Summary

Affiliation: Jacobi Medical Center
Country: USA

Publications

  1. ncbi request reprint Effectiveness of the recombinant factor VIIa in patients with the coagulopathy of advanced child's B and C cirrhosis
    D Bernstein
    Division of Gastroenterology and Hepatology, North Shore University Hospital, Manhasset, New York 11030, USA
    Semin Thromb Hemost 26:437-8. 2000
  2. ncbi request reprint Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients
    David Bernstein
    North Shore University Hospital, 300 Community Drive, Manhasset, NY 11030, USA
    Hepatology 35:704-8. 2002
  3. ncbi request reprint Cost-effectiveness of treatment for chronic hepatitis C infection
    David Bernstein
    JAMA 290:1993; author reply 1994. 2003
  4. ncbi request reprint Treatment of chronic hepatitis C in a state correctional facility
    David Bernstein
    Ann Intern Med 140:150-1; author reply 151. 2004
  5. ncbi request reprint Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose
    Stephanos J Hadziyannis
    Department of Medicine and Hepatology, Henry Dunant Hospital, Athens, Greece
    Ann Intern Med 140:346-55. 2004
  6. ncbi request reprint Pegylated interferon alpha-2a with or without ribavirin in HCV/HIV coinfection: partially blinded, randomized multicenter trial
    Mandana Khalili
    University of California, San Francisco, San Francisco, California, USA
    Dig Dis Sci 50:1148-55. 2005
  7. ncbi request reprint Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: a randomized trial
    Ira M Jacobson
    Weill Medical College of Cornell University, Center for the Study of Hepatitis C, New York Presbyterian Hospital, New York, NY 10021, USA
    Hepatology 46:971-81. 2007

Collaborators

Detail Information

Publications7

  1. ncbi request reprint Effectiveness of the recombinant factor VIIa in patients with the coagulopathy of advanced child's B and C cirrhosis
    D Bernstein
    Division of Gastroenterology and Hepatology, North Shore University Hospital, Manhasset, New York 11030, USA
    Semin Thromb Hemost 26:437-8. 2000
    ..Administration of rFVIIa not only corrected the abnormal clotting tests in these patients but also allowed several invasive procedures without the complication of bleeding...
  2. ncbi request reprint Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients
    David Bernstein
    North Shore University Hospital, 300 Community Drive, Manhasset, NY 11030, USA
    Hepatology 35:704-8. 2002
    ..In conclusion, sustained virologic response is associated with improvements in quality of life in patients with or without advanced liver disease. This parameter may be an important consideration in maximizing treatment adherence...
  3. ncbi request reprint Cost-effectiveness of treatment for chronic hepatitis C infection
    David Bernstein
    JAMA 290:1993; author reply 1994. 2003
  4. ncbi request reprint Treatment of chronic hepatitis C in a state correctional facility
    David Bernstein
    Ann Intern Med 140:150-1; author reply 151. 2004
  5. ncbi request reprint Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose
    Stephanos J Hadziyannis
    Department of Medicine and Hepatology, Henry Dunant Hospital, Athens, Greece
    Ann Intern Med 140:346-55. 2004
    ..Treatment with pegylated interferon (peginterferon) and ribavirin for 48 weeks is more effective than conventional interferon and ribavirin in patients with chronic hepatitis C...
  6. ncbi request reprint Pegylated interferon alpha-2a with or without ribavirin in HCV/HIV coinfection: partially blinded, randomized multicenter trial
    Mandana Khalili
    University of California, San Francisco, San Francisco, California, USA
    Dig Dis Sci 50:1148-55. 2005
    ..PegIFNalpha-2a was therefore at least as effective as standard interferon and ribavirin combination therapy and was well tolerated, without a negative impact on HIV parameters...
  7. ncbi request reprint Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: a randomized trial
    Ira M Jacobson
    Weill Medical College of Cornell University, Center for the Study of Hepatitis C, New York Presbyterian Hospital, New York, NY 10021, USA
    Hepatology 46:971-81. 2007
    ..8% and 59.5%, respectively) regardless of treatment duration. Besides greater hemoglobin reductions with weight-based RBV, safety profiles were similar across RBV dosing groups, including the 1400-mg/day group...